Epinastine + Pseudoephedrine SR (Slow Release) Versus Epinastine Alone in Patients With Perennial Allergic Rhinitis

Clinical trial NCT02182518 · COMPLETED

Trial details

NCT number: NCT02182518
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rhinitis, Allergic, Perennial

Start date: 2000-05-01
Primary completion: 2001-07-01
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.